Benchmarking long-read RNA-sequencing technologies with LongBench: a cross-platform reference dataset profiling cancer cell lines with bulk and single-cell approaches

Technical Summary: Benchmarking Long-Read RNA-Sequencing with LongBench

Problem Statement
While long-read RNA sequencing (RNA-seq) offers distinct advantages for full-length transcript profiling and improved isoform resolution compared to short-read methods, the field faces significant challenges in standardization. The landscape is characterized by variable sequencing platforms and rapidly evolving chemistries, creating a need for careful benchmarking to ensure reliable application. Without robust reference data, researchers struggle to select appropriate technologies or interpret results consistently across different experimental setups.

Methodology
To address these challenges, the authors introduce LongBench, a comprehensive, matched, multi-platform reference dataset designed to facilitate cross-platform evaluation. The study utilizes eight human lung cancer cell lines as the biological basis, incorporating synthetic spike-in controls to provide ground truth for accuracy assessment.

The experimental design spans multiple transcriptomic approaches:

• Sample Types: Bulk RNA-seq, single-cell RNA-seq (scRNA-seq), and single-nucleus RNA-seq (snRNA-seq).
• Sequencing Protocols: The dataset integrates three state-of-the-art long-read protocols alongside Illumina short-read sequencing for comparison:
  1. Oxford Nanopore Technologies (ONT) PCR-cDNA.
  2. ONT direct RNA.
  3. PacBio Kinnex.

The authors systematically evaluate performance across several critical metrics: transcript capture efficiency, quantification accuracy, differential expression analysis, isoform usage, variant detection, and allele-specific analyses.

Key Contributions
The primary contribution of this work is the release of LongBench, described as one of the largest publicly available long-read benchmarking resources to date. By providing a matched dataset that includes both bulk and single-cell/nucleus modalities across multiple long-read technologies, the study offers a standardized framework for rigorous cross-platform evaluation. This resource is intended to guide researchers in technology selection for transcriptomic research.

Results
The systematic evaluation yielded several key findings regarding the consistency and limitations of current long-read technologies:

• Gene-Level Analysis: There is high concordance in gene-level differential expression analyses across the different protocols, suggesting robustness for standard gene-centric studies.
• Transcript and Isoform Analysis: Consistency is notably reduced at the transcript and isoform levels. The authors attribute this to length-dependent and platform-dependent biases, indicating that isoform resolution remains more sensitive to the specific technology used.
• Single-Cell vs. Bulk: Single-cell long-read data demonstrates high concordance with bulk data for high-confidence features.
• Single-Nucleus Limitations: In contrast to bulk and single-cell data, single-nucleus data showed reduced feature detection, highlighting specific challenges in applying long-read sequencing to nuclear isolates.

Significance
The paper positions LongBench as a critical tool for the community to navigate the complexities of long-read RNA sequencing. By providing a matched, multi-platform dataset with synthetic controls, the study enables researchers to move beyond anecdotal comparisons toward rigorous, data-driven evaluations. The authors assert that this resource is essential for guiding technology selection and ensuring the reliability of transcriptomic research, particularly as the field continues to evolve with new chemistries and platforms.